Solventum Corporation/$SOLV
1D1W1MYTD1Y5YMAX
About Solventum Corporation
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.
- Ticker
- $SOLV
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 20,584
- Headquarters
- Eagan, United States
- Website
- www.solventum.com
SOLV Metrics
BasicAdvanced
$15B
11.10
$8.19
0.67
-
Price and volume
Market cap
$15B
Beta
0.67
52-week high
$92.71
52-week low
$62.38
Average daily volume
1.2M
Financial strength
Current ratio
1.021
Quick ratio
0.501
Long term debt to equity
99.729
Total debt to equity
110.313
Interest coverage (TTM)
2.39%
Profitability
EBITDA (TTM)
1,074
Gross margin (TTM)
54.78%
Net profit margin (TTM)
17.26%
Operating margin (TTM)
6.84%
Effective tax rate (TTM)
15.45%
Revenue per employee (TTM)
$400,000
Management effectiveness
Return on assets (TTM)
2.70%
Return on equity (TTM)
33.96%
Valuation
Price to earnings (TTM)
11.098
Price to revenue (TTM)
1.903
Price to book
3.22
Price to tangible book (TTM)
-4.78
Price to free cash flow (TTM)
-134.006
Free cash flow yield (TTM)
-0.75%
Free cash flow per share (TTM)
-0.679
Growth
Revenue change (TTM)
-0.93%
Earnings per share change (TTM)
275.10%
3-year revenue growth (CAGR)
0.85%
3-year earnings per share growth (CAGR)
4.05%
What the Analysts think about SOLV
Analyst ratings (Buy, Hold, Sell) for Solventum Corporation stock.
SOLV Financial Performance
Revenues and expenses
SOLV Earnings Performance
Company profitability
SOLV News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.